AN: Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients ((americasnewsroom__)) ((lubuntu at wor2))

Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins ‘America’s Newsroom’ to explain

Create your own website, free on WordPress.com.Create your own website.
Start free